Sec. 736.
105 words·~1 min read·
/bill/114/s/2956/pcs/section-736A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
None of the funds made available by this Act may be used to notify a sponsor or otherwise acknowledge receipt of a submission for an exemption for investigational use of a drug or biological product under section 505(i) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(i) ) or section 351(a)(3) of the Public Health Service Act ( 42 U.S.C. 262(a)(3) ) in research in which a human embryo is intentionally created or modified to include a heritable genetic modification. Any such submission shall be deemed to have not been received by the Secretary, and the exemption may not go into effect.
Connections2 off-index
2 references not yet in our index
- 21 USC 355(i)
- 42 USC 262(a)(3)
Citation graph
cites case law
Sec. 736
Cite21 USC 355(i)
Cite42 USC 262(a)(3)
Cites 2Cited by 0 across 0 sources